CN116018144A - 一种含有源自Astraeus Asiaticus的治疗剂的抗病毒药物组合物 - Google Patents

一种含有源自Astraeus Asiaticus的治疗剂的抗病毒药物组合物 Download PDF

Info

Publication number
CN116018144A
CN116018144A CN202180037605.6A CN202180037605A CN116018144A CN 116018144 A CN116018144 A CN 116018144A CN 202180037605 A CN202180037605 A CN 202180037605A CN 116018144 A CN116018144 A CN 116018144A
Authority
CN
China
Prior art keywords
astraeus
acyclovir
asiaticus
pharmaceutical composition
extract
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202180037605.6A
Other languages
English (en)
Chinese (zh)
Inventor
布兰特·塔萨尼特利塔普
金塔纳·法旺
纳萨吉·努尔凯
通坤·普里恩普洛姆
詹提普·萨莱
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mahidol University
Original Assignee
Mahidol University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from TH2001003370A external-priority patent/TH2001003370A/th
Application filed by Mahidol University filed Critical Mahidol University
Publication of CN116018144A publication Critical patent/CN116018144A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
CN202180037605.6A 2020-06-15 2021-04-30 一种含有源自Astraeus Asiaticus的治疗剂的抗病毒药物组合物 Pending CN116018144A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
TH2001003370A TH2001003370A (th) 2020-06-15 องค์ประกอบทางเภสัชภัณฑ์จากเห็ดเผาะฝ้ายสำหรับต้านเชื้อไวรัส
TH2001003370 2020-06-15
PCT/TH2021/000016 WO2021257007A1 (fr) 2020-06-15 2021-04-30 Composition pharmaceutique antivirale contenant un agent thérapeutique provenant d'astraeus asiaticus

Publications (1)

Publication Number Publication Date
CN116018144A true CN116018144A (zh) 2023-04-25

Family

ID=79268153

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202180037605.6A Pending CN116018144A (zh) 2020-06-15 2021-04-30 一种含有源自Astraeus Asiaticus的治疗剂的抗病毒药物组合物

Country Status (2)

Country Link
CN (1) CN116018144A (fr)
WO (1) WO2021257007A1 (fr)

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1179717A (zh) * 1995-02-06 1998-04-22 阿斯特拉公司 新的药物组合物
CN1989989A (zh) * 2005-12-26 2007-07-04 浙江海正天华新药研发有限公司 六棱菊属植物提取物抑制单纯疱疹病毒及乙肝病毒的用途
CA2873461A1 (fr) * 2012-05-14 2013-11-21 Biocogent, Llc Prevention de la defaillance des fibroblastes
CN105394045A (zh) * 2014-09-04 2016-03-16 中国科学院上海巴斯德研究所 一种肠道病毒的小分子化合物抑制剂及其应用
CN105722977A (zh) * 2013-10-30 2016-06-29 绿色生活生物技术有限责任公司 用于柑橘绿化枯萎病的发病定量系统和治疗方法
CN108619123A (zh) * 2018-03-13 2018-10-09 武汉威立得生物医药有限公司 Tenovin-1在制备防治人类疱疹病毒感染药物中的应用
CN109965166A (zh) * 2019-04-12 2019-07-05 龚洁敏 一种香菇多糖饮料的生产方法

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1179717A (zh) * 1995-02-06 1998-04-22 阿斯特拉公司 新的药物组合物
CN1989989A (zh) * 2005-12-26 2007-07-04 浙江海正天华新药研发有限公司 六棱菊属植物提取物抑制单纯疱疹病毒及乙肝病毒的用途
CA2873461A1 (fr) * 2012-05-14 2013-11-21 Biocogent, Llc Prevention de la defaillance des fibroblastes
CN105722977A (zh) * 2013-10-30 2016-06-29 绿色生活生物技术有限责任公司 用于柑橘绿化枯萎病的发病定量系统和治疗方法
CN105394045A (zh) * 2014-09-04 2016-03-16 中国科学院上海巴斯德研究所 一种肠道病毒的小分子化合物抑制剂及其应用
CN108619123A (zh) * 2018-03-13 2018-10-09 武汉威立得生物医药有限公司 Tenovin-1在制备防治人类疱疹病毒感染药物中的应用
CN109965166A (zh) * 2019-04-12 2019-07-05 龚洁敏 一种香菇多糖饮料的生产方法

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
ARPHA K，ET AL: "Astraodoric Acids A–D: New Lanostane Triterpenes from Edible Mushroom Astraeus odoratus and Their Anti- Mycobacterium tuberculosis H 37 Ra and Cytotoxic Activity", JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, vol. 60, 10 September 2012 (2012-09-10), pages 9834 - 9841, XP055721231, DOI: 10.1021/jf302433r *
ISAKA，ET AL: "Lanostane triterpenoids from the edible mushroom Astraeus asiaticus", TETRAHEDRON, vol. 73, no. 12, 6 February 2017 (2017-02-06), pages 1561 - 1567, XP055894364, DOI: 10.1016/J.TET. 2017.01.07 0 *
LI X，ET AL: "Ergosterol purified from medicinal mushroom Amauroderma rude inhibits cancer growth in vitro and in vivo by up-regulating multiple tumor suppressors", ONCOTARGET, vol. 06, no. 19, 27 May 2015 (2015-05-27), pages 17832 - 17845 *
PHADANNOK P , ET AL: "Enhancing glucose uptake by Astraeus odoratus and Astraeus asiaticus extracts in L6 myotubes", PHARMACOGNOSY MAGAZINE, vol. 16, no. 67, 11 February 2020 (2020-02-11), pages 34 - 42, XP018536821 *
王慧英，等: "阿昔洛韦――一种抗疱疹病毒特效药", 中国新药与临床杂志, no. 01, 19 February 1990 (1990-02-19), pages 19 - 21 *

Also Published As

Publication number Publication date
WO2021257007A1 (fr) 2021-12-23

Similar Documents

Publication Publication Date Title
Docherty et al. Resveratrol inhibition of varicella-zoster virus replication in vitro
JPH03505325A (ja) レトロウイルス感染治療法
CN113855654B (zh) 一种预防和治疗冠状病毒感染的组合物
KR20090112151A (ko) 라우릭산을 유효성분으로 함유하는 항바이러스제 조성물
CN113648337B (zh) 雷公藤红素在制备抑制马立克氏病病毒复制的药物中的应用
WO2021218422A1 (fr) Application d'une composition de médecine traditionnelle chinoise dans la préparation de médicaments permettant le traitement ou la prévention d'une infection par le coronavirus
US20030054047A1 (en) Pharmaceutical composition for the treatment of viral infection
CN116018144A (zh) 一种含有源自Astraeus Asiaticus的治疗剂的抗病毒药物组合物
US9192640B2 (en) Antiviral composition against flavivirus
CN111329859B (zh) 叶绿素铜钠盐在制备用于抗肠道病毒的药物中的应用
CN113181152B (zh) Tiratricol化合物在制备抗EV71病毒药物中的应用
KR101660815B1 (ko) 테트라싸이클린 유도체, 이의 약학적으로 허용가능한 염 또는 이의 입체이성질체를 유효성분으로 함유하는 바이러스성 질환의 예방 또는 치료용 약학적 조성물
CN102885841B (zh) 安石榴苷的应用
CN107158005B (zh) 救必应酸在制备抗流感病毒药物中的应用
CN116018143A (zh) 用于治疗由sars-cov-2病毒引起的病毒感染的包含地尔硫卓的组合物
CN105434631A (zh) 花椒精油在制备用于预防和/或治疗病毒性流感的药物或保健品中的应用
KR100668689B1 (ko) 라이노바이러스에 대한 항바이러스 조성물
CN111317739A (zh) 依托红霉素在制备特异性抑制病毒感染的药物中的用途
KR20160071245A (ko) 항 콕사키바이러스 활성을 갖는 오리방풀 유래 화합물
JP5173813B2 (ja) インフルエンザの予防および処置のための薬剤
CN111617076B (zh) 一种含有盐酸阿比多尔的复方药物组合物及其用途
US20210379132A1 (en) COMPOSITIONS INCLUDING GINSENOSIDE 20(S)-Rg3 AND METHODS OF USING GINSENOSIDE 20(S)-Rg3 TO INHIBIT ALPHA HERPESVIRUS
TWI811724B (zh) 正股核糖核酸病毒之抑制劑
TWI304342B (en) An herbal extract having anti- enterovirus activity and preparation of same
US20230233640A1 (en) Antiviral preparation from chestnut shells of castanea sativa mill

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination